Susquehanna Private Capital (SPC), a middle market private equity firm, has invested in Spherix Global Insights (Spherix), a pharmaceutical market insights firm focused on the dermatology, gastroenterology, nephrology, neurology, ophthalmology, and rheumatology specialties.
Terms of the transaction have not been disclosed.
Founded in 2015 by Jennifer and Kevin Robinson, Spherix provides pharmaceutical market insights and intelligence through its proprietary network of over 3,000 active specialty providers and their patients.
360 Ventures, LLC acted as exclusive financial advisor and WilmerHale and Walder Wyss served as legal advisors to Spherix. Troutman Pepper served as legal advisor to SPC. Monroe Capital provided debt financing to support the transaction.
